2007-04-24 06:30:17 -

COLUMBUS, Ohio, April 24 /PRNewswire/ -- Roxane Laboratories, Inc. today announced the launch of Zolpidem Tartrate Tablets CIV, 5mg and 10mg. The product will be available in bottles of 100 and 500, as well as a 100 count Unit Dose package.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO )

Roxane Laboratories' Zolpidem Tartrate Tablets CIV, 5 mg and 10mg are AB rated to AMBIEN(R) (zolpidem tartrate) Tablets CIV, 5 mg and 10mg. Zolpidem Tartrate Tablets CIV had total annual sales of approximately $2.1 Billion, based on IMS sales data for the twelve months

ending December 2006.

Full prescribing information for Zolpidem Tartrate Tablets CIV, 5mg and 10mg is available on the Roxane web site at http://www.roxane.com/ or upon request by calling Roxane Laboratories Technical Product Information at 1-800-962-8364.

Roxane Laboratories

Roxane Laboratories, Inc. (Columbus, Ohio), is a subsidiary of Boehringer Ingelheim Corporation, based in Ridgefield, CT and a member of the Boehringer Ingelheim group of companies.

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 137 affiliates in 47 countries and approximately 38,400 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine.

In 2006, Boehringer Ingelheim posted net sales of US $13.3 billion (10.6 billion euro) while spending approximately one-fifth of net sales in its largest business segment, Prescription Medicines, on research and development.

For more information, please visit http://us.boehringer-ingelheim.com/.

AMBIEN(R) is a registered trademark of Sanofi-Aventis

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20070410/CLTU122LOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com

Source: Roxane Laboratories